Clinical Trials Logo

Filter by:
  • Completed  
  • « Prev · Page [19]
NCT ID: NCT00255567 Completed - Clinical trials for Visceral Leishmaniasis

Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of SSG 30 days alone, PM 21 days alone and SSG and PM as a combination course of 17 days in the treatment of patients with VL.

NCT ID: NCT00221364 Completed - Chlamydia Clinical Trials

Trachoma Elimination Follow-up

TEF
Start date: March 2003
Phase: Phase 4
Study type: Interventional

The WHO has initiated a program to eliminate blinding trachoma by the year 2020, in large part by mass oral azithromycin distributions. It is not clear how frequently or for how long these treatments are necessary. Here we assess the frequency and duration of treatment.

NCT ID: NCT00074399 Completed - HIV Infections Clinical Trials

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV

Start date: February 2001
Phase: Phase 3
Study type: Interventional

HIV can be transmitted from an HIV infected mother to her infant through her breast milk. The purpose of this study is to determine whether giving infants of HIV infected mothers the anti-HIV drug nevirapine (NVP) for six weeks will reduce the risk of HIV transmission. Study hypothesis: Six weeks of nevirapine prophylaxis provided to the infant will decrease HIV transmission through breastfeeding.

NCT ID: NCT00002399 Completed - HIV Infections Clinical Trials

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC (a fungal infection of the throat) in HIV-positive patients.